Government health data mining practices: Big Brother or better care?

Government agencies increasingly mine Medicare health insurance claims to identify and reach out to vulnerable people, especially during emergencies. A recent New York Times articles delves into the privacy and ethical quandaries surrounding this practice, and whether the benefits outweighs these concerns.

Read the full article below:

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.